These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 35420272)
1. Efficient 18F-fluorodeoxyglucose positron emission tomography/computed tomography-based machine learning model for predicting epidermal growth factor receptor mutations in non-small cell lung cancer. Ruan D; Fang J; Teng X Q J Nucl Med Mol Imaging; 2024 Mar; 68(1):70-83. PubMed ID: 35420272 [TBL] [Abstract][Full Text] [Related]
2. Value of pre-therapy Zhang J; Zhao X; Zhao Y; Zhang J; Zhang Z; Wang J; Wang Y; Dai M; Han J Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1137-1146. PubMed ID: 31728587 [TBL] [Abstract][Full Text] [Related]
3. Radiogenomic Models Using Machine Learning Techniques to Predict EGFR Mutations in Non-Small Cell Lung Cancer. Nair JKR; Saeed UA; McDougall CC; Sabri A; Kovacina B; Raidu BVS; Khokhar RA; Probst S; Hirsh V; Chankowsky J; Van Kempen LC; Taylor J Can Assoc Radiol J; 2021 Feb; 72(1):109-119. PubMed ID: 32063026 [TBL] [Abstract][Full Text] [Related]
4. An [ Meng N; Feng P; Yu X; Wu Y; Fu F; Li Z; Luo Y; Tan H; Yuan J; Yang Y; Wang Z; Wang M Eur Radiol; 2024 Jan; 34(1):318-329. PubMed ID: 37530809 [TBL] [Abstract][Full Text] [Related]
5. Value of multi-center Zuo Y; Liu L; Chang C; Yan H; Wang L; Sun D; Ruan M; Lei B; Xia X; Xie W; Song S; Huang G Med Phys; 2024 Jul; 51(7):4872-4887. PubMed ID: 38285641 [TBL] [Abstract][Full Text] [Related]
6. Next-Generation Radiogenomics Sequencing for Prediction of EGFR and KRAS Mutation Status in NSCLC Patients Using Multimodal Imaging and Machine Learning Algorithms. Shiri I; Maleki H; Hajianfar G; Abdollahi H; Ashrafinia S; Hatt M; Zaidi H; Oveisi M; Rahmim A Mol Imaging Biol; 2020 Aug; 22(4):1132-1148. PubMed ID: 32185618 [TBL] [Abstract][Full Text] [Related]
7. Value of Lv Z; Fan J; Xu J; Wu F; Huang Q; Guo M; Liao T; Liu S; Lan X; Liao S; Geng W; Jin Y Eur J Nucl Med Mol Imaging; 2018 May; 45(5):735-750. PubMed ID: 29164298 [TBL] [Abstract][Full Text] [Related]
8. Machine learning based on clinico-biological features integrated Ren C; Zhang J; Qi M; Zhang J; Zhang Y; Song S; Sun Y; Cheng J Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1538-1549. PubMed ID: 33057772 [TBL] [Abstract][Full Text] [Related]
9. IMPORTANCE of PRETREATMENT 18F-FDG PET/CT TEXTURE ANALYSIS in PREDICTING EGFR and ALK MUTATION in PATIENTS with NON-SMALL CELL LUNG CANCER. Agüloğlu N; Aksu A; Akyol M; Katgı N; Doksöz TÇ Nuklearmedizin; 2022 Dec; 61(6):433-439. PubMed ID: 35977671 [TBL] [Abstract][Full Text] [Related]
10. Predictive value of multiple metabolic and heterogeneity parameters of Shi A; Wang J; Wang Y; Guo G; Fan C; Liu J Ann Nucl Med; 2022 Apr; 36(4):393-400. PubMed ID: 35084711 [TBL] [Abstract][Full Text] [Related]
11. Machine learning for differentiating lung squamous cell cancer from adenocarcinoma using Clinical-Metabolic characteristics and 18F-FDG PET/CT radiomics. Zhang Y; Liu H; Chang C; Yin Y; Wang R PLoS One; 2024; 19(4):e0300170. PubMed ID: 38568892 [TBL] [Abstract][Full Text] [Related]
12. [ Yang M; Li X; Cai C; Liu C; Ma M; Qu W; Zhong S; Zheng E; Zhu H; Jin F; Shi H Eur Radiol; 2024 Jul; 34(7):4352-4363. PubMed ID: 38127071 [TBL] [Abstract][Full Text] [Related]
13. Development and Validation of Machine Learning Models to Predict Epidermal Growth Factor Receptor Mutation in Non-Small Cell Lung Cancer: A Multi-Center Retrospective Radiomics Study. Liu Y; Zhou J; Wu J; Wang W; Wang X; Guo J; Wang Q; Zhang X; Li D; Xie J; Ding X; Xing Y; Hu D Cancer Control; 2022; 29():10732748221092926. PubMed ID: 35417660 [TBL] [Abstract][Full Text] [Related]
14. 18F-FDG uptake for prediction EGFR mutation status in non-small cell lung cancer. Guan J; Xiao NJ; Chen M; Zhou WL; Zhang YW; Wang S; Dai YM; Li L; Zhang Y; Li QY; Li XZ; Yang M; Wu HB; Chen LH; Liu LY Medicine (Baltimore); 2016 Jul; 95(30):e4421. PubMed ID: 27472739 [TBL] [Abstract][Full Text] [Related]
16. Usefulness of gradient tree boosting for predicting histological subtype and EGFR mutation status of non-small cell lung cancer on Koyasu S; Nishio M; Isoda H; Nakamoto Y; Togashi K Ann Nucl Med; 2020 Jan; 34(1):49-57. PubMed ID: 31659591 [TBL] [Abstract][Full Text] [Related]
17. Combination of Li S; Li Y; Zhao M; Wang P; Xin J Korean J Radiol; 2022 Sep; 23(9):921-930. PubMed ID: 36047542 [TBL] [Abstract][Full Text] [Related]
18. Role of [¹⁸F]FDG PET in prediction of KRAS and EGFR mutation status in patients with advanced non-small-cell lung cancer. Caicedo C; Garcia-Velloso MJ; Lozano MD; Labiano T; Vigil Diaz C; Lopez-Picazo JM; Gurpide A; Zulueta JJ; Richter Echevarria JA; Perez Gracia JL Eur J Nucl Med Mol Imaging; 2014 Nov; 41(11):2058-65. PubMed ID: 24990403 [TBL] [Abstract][Full Text] [Related]
19. A Machine Learning Model Based on PET/CT Radiomics and Clinical Characteristics Predicts Tumor Immune Profiles in Non-Small Cell Lung Cancer: A Retrospective Multicohort Study. Tong H; Sun J; Fang J; Zhang M; Liu H; Xia R; Zhou W; Liu K; Chen X Front Immunol; 2022; 13():859323. PubMed ID: 35572597 [TBL] [Abstract][Full Text] [Related]
20. Fusion of shallow and deep features from Yao X; Zhu Y; Huang Z; Wang Y; Cong S; Wan L; Wu R; Chen L; Hu Z Quant Imaging Med Surg; 2024 Aug; 14(8):5460-5472. PubMed ID: 39144023 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]